Los mejores cirujanos cardíacos — TOP-412 médicos

Educación

1973-1979 - Facultad de Medicina: Segunda Universidad Médica, Moscú, URSS.

Especialización

1981-1986 - Instituto de Cirugía Cardiovascular. Kolbe, Moscú, URSS

Experiencia reconocida

Especialista en Cirugía Cardíaca y Torácica

Educación adicional

• 1995 - Curso ATLS en la Escuela Médica Militar.
• 1996 - Curso de formación en MIDCAB en la Universidad de Ciatti, Italia.
• 1998 Curso de formación de válvulas, Medtronic Freestyle Stentless en Oxford, Inglaterra.
• 1999- Curso LVAD en DHZB, Berlín, Alemania
• 2000 - Curso de formación sobre válvulas SPV sin stent en Copenhague, Dinamarca.

Experiencia clínica

• Desde 1996 - Médico principal del Departamento de Cirugía Cardíaca, Centro Médico de Tel Aviv, Ichilov.
• 1991-1996 - Pasantía, Departamento de Cirugía Cardíaca, Centro Médico de Tel Aviv, Ichilov.
• 1990-1986 - Cirujano del Departamento de Cirugía Cardiaca Pediátrica, Instituto de Cirugía Cardiovascular del mismo nombre. Kolba, Moscú, URSS
• 1986-1981 - pasantía, Instituto de Cirugía Cardiovascular. Kolbe, Moscú, URSS.
• 1981-1979- Satch, Instituto de Cirugía Cardiovascular. Kolbe, Moscú, URSS

Experiencia academica

• 1992-2000 - Facultad de Medicina, Universidad de Tel Aviv - enseñanza y formación de estudiantes de medicina, quinto año.
• 1991-2000 - Escuela Académica de Enfermería de Scheinbron, Universidad de Tel Aviv - Enseñanza de 4 hermanos, así como hermanos de UCI y quirófano.

Membresía de la unión

Asociación Médica de Israel

Educación

1978-1984 Universidad Ben-Gurion de la Facultad de Medicina de Negev.

Especialización

• 1985-1990 Pasantía en Medicina Interna, Centro Médico de Tel Aviv
• 1991-1994 Internado en Cardiología, Centro Médico de Tel Aviv.
• 1998-2000 Especialización en Cardiología Intervencionista (Cateterismo), Hospital Cedar Sinai

Experiencia Reconocido

• Medicina Interna
• Cardiología

Educación adicional

1998-2000 - Cardiología Intervencionista, Universidad de California, Los Ángeles.

Experiencia clínica

• 2005 - Director del departamento de cateterismo del departamento de cardiología del Centro Médico de Tel Aviv.
• 1999-2011 Internado en Cardiología Intervencionista, UCLA, EE. UU.
• 1996-1999 Director del Departamento de Rehabilitación de Pacientes Cardíacos, Centro Médico de Tel Aviv.
• 1993-1996 Médico principal, Departamento de Cardiología, Centro Médico de Tel Aviv.
• 1990-1993 Especialización en Cardiología, Centro Médico de Tel Aviv.
• 1986-1990 Pasantía en Medicina Interna, Centro Médico de Tel Aviv

Experiencia academica

Profesor, Clinical Fellow, Departamento de Cardiología, Universidad de Tel Aviv

Asistencias a conferencias

Cientos de ponencias en congresos, cursos y seminarios científicos

Publicaciones profesionales

Más de 100 publicaciones científicas en la literatura profesional.

Membresía de la unión

• Presidente del Departamento de Cardiología Intervencionista de Israel
• Asociación Israelí del Corazón
• Asociación Médica Israelí
• Sociedad Americana de Cardiología (ACC)
• Sociedad Europea de Cardiología (EPACI)

Zonas de especial interés y actividades

• Intervenciones en la arteria coronaria
• Cateterismo de válvula aórtica

Personal information

Title: Professor Doctor

Branch: Pulmonary Diseases

Work History:

1  Ilıca Health Center \ Health Center Physician (Compulsory Service)

2   Florence Nightingale Hospital

3   Onze Lieve Vrouw Clinic (OLV) Aalst Belgium

4   Istanbul Bilim University (Assistant Professor)

5   Florence Nightingale Hospital (Associate Professor)

6   Istanbul Bilim University (Professor)

Medical Specialties and Subspecialties:

1   Minimally invasive heart surgery

2   Aortic surgery

3   Cover Repairs

4   Arrhythmia Surgery

Special advanced health technologies:

1   Robotic heart surgery (Da Vinci Robotic System)

2   Port Access Surgery

Education

1991 - Selçuk University Faculty of Medicine

1998 - Istanbul University Cardiology Institute (Specialization)

El Dr. Francesco Bedogni es cardiólogo intervencionista en el Hospital San Donato de Milán y supervisor europeo de TAVI y MITRACLIP. Es miembro de la junta de la Sociedad Italiana de Cardiología Intervencionista y es responsable de múltiples estudios clínicos y documentos de posición.

cirujano cardíaco pediátrico

Dr. Lucia Torracca is leading the Cardiac Surgery Unit at Humanitas Research Hospital. She received her training at Ospedali Civili di Brescia and at Ospedale San Raffaele with Professor Ottavio Alfieri, were she improved her knowledge in the mitral disease focusing in the reparative and preservative approaches. At the same institution she led the minimal invasive and robotic division before moving to Ospedali Riuniti Di Ancona to be chief of the Cardiac Surgery Complex Unit. Dr. Torracca has performed more than 55 hundred cardiac surgeries. Thanks to her surgical and academic curriculum, she has been an active member of the steering committee of the European Society editing Guidelines for the treatment of heart diseases.

Together with her team in Humanitas, she can approach every cardiac disease affecting adults, especially focusing on the minimal invasive approach to reparative valve disease. State of the art technologies are regularly explored and implemented in the Open Heart dedicated Operating Room and Intensive Care Unit to ensure best outcomes, shorter hospital stay and fewer surgical complications.

The surgical expertise of Dr. Torracca go from open heart circulatory-arrest procedure to off-pump and/or trans-catheter procedures (MitraClip or TransApical Aortic Valve Implants).

Dr. Torracca and her team can claim the highest rate of mitral valve repair in Bi-leaflet prolapse (Barlow Disease) hitting almost 99% of conservative approach in minimal invasiveness at the time of surgery, maintaining >95% success rate at long term follow up: this option is further advantageous in the youngest patient population allowing restrain from anticoagulation therapy and perfectly normal quality of life.

Author or co-author of 151 publications in national and international scientific journals.

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21

Academic Education:

• Graduated in Medicine and Surgery in 1984 from the University of Barcelona Autonomous.
• Specialist in Cardiovascular Surgery, residency held at the University Hospital La Pitié-Salpétrière in Paris, France during the period 1985-1990.
• Title of Qualified Specialist Physician in General Surgery by the Departmental Council of the College of Physicians of Paris in 1990.
• Title of the French College of Thoracic and Cardiovascular Surgery in 1991.
• Title of Competent Qualified Physician in Thoracic Surgery at the Departmental Council of the College of Physicians of Paris in 1993.
• Medical Specialist in Cardiovascular Surgery.
• Title of Fellow of the European Board of Thoracic and Cardiovascular Surgeons in 1999.

Scientific and Teaching Activity:

• Head of the Cardiac Surgery Service of the Bellvitge University Hospital in Barcelona.
• Assistant Chair of Surgery at the Universitat Pierre et Marie Curie Paris VI.
• President of the Catalan Society of Cardiac Surgery 2009-2011.
• Member of the Catalan Society of Surgery.
• Member of the Catalan Society of Cardiology.
• Member of the Board of the Spanish Society of Thoracic-Cardiovascular Surgery (SECTCV).
• Member of the European Association for Cardiovascular and Thoracic Surgery (EACTS).
• Member of the International Society for Heart and Lung Transplantation (ISHLT).
• Member of the Spanish Society of Cardiology (SEC).
• Collaboration in various research projects.
• 44 publications in International Magazines.
• 22 publications in National Magazines.
• Multiple communications in Meetings and Congresses (more than 150).

Dr. Bernhard Reimers – Clinical and Invasive Cardiology Unit Director in Humanitas Research Hospital, was born in Germany. He graduated in medicine and surgery in University of Padua (Italy) in 1990, followed by specialization in Cardiology. During the first 3 years of specialization in Cardiology in the Coronary Unit of Padua University, his particular interests were in managing cardiovascular urgency and critical patients, including management of fans, balloon pump, hemofiltration, temporary pacing, placement of central venous pathways and Swan-Ganz catheter. He spent his last year of specialization at the Hemodynamics of Casa di Cura Columbus (Milan), where he acquired his knowledge on the main diagnostic techniques he uses. After a short period of study at the Thoraxcenter of Rotterdam, during which he wrote his first scientific publications, Dr. Reimers has dedicated himself to hemodynamics and cardiovascular surgeries, working as Unit Director main assistant, executing angioplasty, coronary and peripheral procedures, reaching complete autonomy in coronary stenting, atherectomy, ultrasound intravascular and intracoronary doppler.

Since September 1997 he has managed and developed the diagnostic and interventional cardiovascular program at the Department of Cardiology of Mirano (Venice), where, thanks to his achievements, since 2000 the highest number of coronary angioplasties were performed. In 2006 the Unit has performed 975 coronary angioplasties (including 125 primary), more than 400 carotid angioplasty and peripherals. Dr. Reimers became Unit Director and has trained and taught a young team of interventional cardiologists, including 4 completely independent in the performance of coronary angioplasty, which manages both hemodynamics and largely the CCU in close collaboration between the two services. After this important experience, he was invited to be part of Humanitas Research Hospital as Clinical and Invasive Cardiology Unit Director.

Dr. Reimers participates in many scientific studies on the treatment of myocardial infarction considering new interventional or pharmaceutical approaches for primary angioplasty. He was also member of the Technical Commission of the Regional Bid for the purchase of stents. Thanks to Dr. Reimers’ efforts, Hemodynamics of Mirano (Venice) is considered reference center for primary angioplasty and elective complex procedures. Dr. Reimers is considered to be one of the leading experts of carotid angioplasty worldwide. He is preparing a program for interventional treatment of acute stroke. He performs routine renal angioplasty and implants percutaneous devices and endoprosthesis systems for aortic aneurysms.

Dr. Reimers has published, as author or co-author, 77 articles quoted in Medline. The impact factor calculated based on 2006 is 263. He published 9 book chapters and several abstracts for important international conferences dedicated to Cardiology, such as TCT, PCR, National GISE ANMCO, JIM and ESC, were he also performed live invasive procedures.

Dr. Reimers has always considered participation in clinical trials and scientific international events among the main activities of his professional carrier. Besides teaching at University of Tor Vergata in Rome, he organizes many conferences, national and international medical follow-up courses. For over 9 years he has been organizing theoretical and practical courses with lectures and transmission of live procedures in Venice. He has so far organized two editions of TOBI, international meeting dedicated to invasive treatment of total coronary occlusions and bifurcations, three editions of ETI, international conference and the largest in Italy, dedicated to invasive cardiology devices. 

Dr. Reimers was member of the scientific committee in the editions of 2006 and 2007 of National Convention GISE (Italian Group of Hemodynamic Study) and participated at important events dedicated to CAPTURE study, ESIRIUS, SYNTAX, TIMI 38, FINESSE and many others.

Publications: ttp://www.ncbi.nlm.nih.gov/pubmed/?term=bernhard